Epidemiology Assessment

Cutaneous Squamous Cell Carcinoma (cSCC) Epidemiology Assessment Across 15 Countries

Performing deep assessment to understand the epidemiological scenario of Cutaneous Squamous Cell Carcinoma

Problem Statement:

A client based in the US wanted the epidemiology assessment exercise to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma (cSCC) for 15 countries, including the US, key European countries, and key countries from APAC.

Our Methodology:
  • Secondary Assessment
  • Primary Assessment
  • Excel-based model and PPT that covers an executive summary on country-specific solid organ transplant scenarios.
  • Percentage of patients who develop cSCC.
  • Valuable KOL insights from each country along with country-specific key findings.

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe, wanted to in-license potential dMTS based drug delivery asset... [...]

View Case
Out Licensing Opportunity
Out-Licensing Opportunity

A small pharmaceutical client based at Sweden, Europe with capabilities around a neonatal mesenchymal cells involved DelveInsight to identify a licensing partner for their stem cells product, from acr... [...]

View Case
Go-To-Market Strategy
Go-To-Market Strategy

A medium pharmaceutical client based in United States with biosimilar commercial capabilities involved DelveInsight to identify commercial processes and strategies to launch their biosimilar in Europe... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.